Department of Public Health Sciences, University of Connecticut School of Medicine, 263 Farmington Ave, Farmington, CT, 06030, USA.
HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute, Columbia University, New York, NY, USA.
Subst Abuse Treat Prev Policy. 2024 Jan 29;19(1):12. doi: 10.1186/s13011-024-00593-y.
People with opioid use disorder (OUD) are frequently in contact with the court system and have markedly higher rates of fatal opioid overdose. Opioid intervention courts (OIC) were developed to address increasing rates of opioid overdose among court defendants by engaging court staff in identification of treatment need and referral for opioid-related services and building collaborations between the court and OUD treatment systems. The study goal was to understand implementation barriers and facilitators in referring and engaging OIC clients in OUD treatment.
Semi-structured interviews were conducted with OIC stakeholders (n = 46) in 10 New York counties in the United States, including court coordinators, court case managers, and substance use disorder treatment clinic counselors, administrators, and peers. Interviews were recorded and transcribed and thematic analysis was conducted, guided by the Exploration, Preparation, Implementation, Sustainment (EPIS) framework, employing both inductive and deductive coding.
Results were conceptualized using EPIS inner (i.e., courts) and outer (i.e., OUD treatment providers) implementation contexts and bridging factors that impacted referral and engagement to OUD treatment from the OIC. Inner factors that facilitated OIC implementation included OIC philosophy (e.g., non-punitive, access-oriented), court organizational structure (e.g., strong court staff connectedness), and OIC court staff and client characteristics (e.g., positive medications for OUD [MOUD] attitudes). The latter two also served as barriers (e.g., lack of formalized procedures; stigma toward MOUD). Two outer context entities impacted OIC implementation as both barriers and facilitators: substance use disorder treatment programs (e.g., attitudes toward the OIC and MOUD; operational characteristics) and community environments (e.g., attitudes toward the opioid epidemic). The COVID-19 pandemic and bail reform were macro-outer context factors that negatively impacted OIC implementation. Facilitating bridging factors included staffing practices that bridged court and treatment systems (e.g., peers); barriers included communication and cultural differences between systems (e.g., differing expectations about OIC client success).
This study identified key barriers and facilitators that OICs may consider as this model expands in the United States. Referral to and engagement in OUD treatment within the OIC context requires ongoing efforts to bridge the treatment and court systems, and reduce stigma around MOUD.
阿片类药物使用障碍(OUD)患者经常与法院系统接触,且致命阿片类药物过量的发生率明显更高。阿片类药物干预法院(OIC)的设立是为了通过让法院工作人员识别治疗需求并转介接受阿片类相关服务,以及建立法院与 OUD 治疗系统之间的合作关系,来解决法庭被告中阿片类药物过量率不断上升的问题。本研究的目的是了解在转介和使 OIC 客户参与 OUD 治疗方面的实施障碍和促进因素。
对美国 10 个纽约县的 OIC 利益相关者(n=46)进行了半结构化访谈,包括法院协调员、法院案件管理人员以及物质使用障碍治疗诊所顾问、管理人员和同行。访谈进行了录音和转录,并进行了主题分析,分析过程以探索、准备、实施、维持(EPIS)框架为指导,采用归纳和演绎编码。
结果根据 EPIS 的内部(即法庭)和外部(即 OUD 治疗提供者)实施背景以及影响 OIC 转介和参与 OUD 治疗的桥梁因素进行了概念化。促进 OIC 实施的内部因素包括 OIC 理念(例如,非惩罚性、以获取为导向)、法院组织结构(例如,强大的法院工作人员联系)以及 OIC 法院工作人员和客户的特征(例如,对治疗阿片类药物使用障碍的积极态度)。后两者也是障碍(例如,缺乏正式程序;对治疗阿片类药物使用障碍的药物的污名化)。两个外部环境实体既作为障碍又作为促进因素影响着 OIC 的实施:物质使用障碍治疗项目(例如,对 OIC 和治疗阿片类药物使用障碍的药物的态度;运营特点)和社区环境(例如,对阿片类药物流行的态度)。COVID-19 大流行和保释改革是对外界环境产生负面影响的宏观因素。促进桥梁的因素包括跨越法院和治疗系统的人员配置做法(例如,同行);障碍包括系统之间的沟通和文化差异(例如,对 OIC 客户成功的期望不同)。
本研究确定了 OIC 可能考虑的关键障碍和促进因素,因为该模型在美国不断扩大。在 OIC 背景下,转介和参与 OUD 治疗需要持续努力来弥合治疗和法院系统之间的差距,并减少对治疗阿片类药物使用障碍的药物的污名化。